electroCore (ECOR) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T22:41:21.491Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:41:21.491Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 9.92
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.7

FMP input reference: 4f3bc52aaee10dc4864d073eee8720ed85d0d11e7a3d16422bde167dd05b99a5

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

ECOR PE Ratio Metrics

PE RATIO

N/A

ECOR Competitors' PE Ratio

ECOR

electroCore, Inc.

Current

Market Cap

$89.44M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EQ

Equillium, Inc.

vs ECOR

Market Cap

$89.78M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ICCC

ImmuCell Corporation

vs ECOR

Market Cap

$90.20M

PE Ratio

117.85

TTM Avg

46.83

3Y Avg

44.28

5Y Avg

282.12

BMEA

Biomea Fusion, Inc.

vs ECOR

Market Cap

$90.37M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RLYB

Rallybio Corporation

vs ECOR

Market Cap

$90.64M

PE Ratio

2.19

TTM Avg

2.16

3Y Avg

2.16

5Y Avg

2.16

CCLD

CareCloud, Inc.

vs ECOR

Market Cap

$87.96M

PE Ratio

29.66

TTM Avg

45.53

3Y Avg

45.53

5Y Avg

24.63

ATRA

Atara Biotherapeutics, Inc.

vs ECOR

Market Cap

$87.85M

PE Ratio

N/A

TTM Avg

3.67

3Y Avg

3.67

5Y Avg

3.67

NMRA

Neumora Therapeutics, Inc. Common Stock

vs ECOR

Market Cap

$87.27M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PARK

Park Dental Partners, Inc. Common Stock

vs ECOR

Market Cap

$92.69M

PE Ratio

N/A

TTM Avg

13.33

3Y Avg

13.33

5Y Avg

13.33

PMVP

PMV Pharmaceuticals, Inc.

vs ECOR

Market Cap

$85.86M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
electroCore, Inc. (ECOR)	$89.44M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$89.78M	N/A	N/A	N/A	N/A
ImmuCell Corporation (ICCC)vs ›	$90.20M	117.85	46.83	44.28	282.12
Biomea Fusion, Inc. (BMEA)vs ›	$90.37M	N/A	N/A	N/A	N/A
Rallybio Corporation (RLYB)vs ›	$90.64M	2.19	2.16	2.16	2.16
CareCloud, Inc. (CCLD)vs ›	$87.96M	29.66	45.53	45.53	24.63
Atara Biotherapeutics, Inc. (ATRA)vs ›	$87.85M	N/A	3.67	3.67	3.67
Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›	$87.27M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$92.69M	N/A	13.33	13.33	13.33
PMV Pharmaceuticals, Inc. (PMVP)vs ›	$85.86M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$9.92

÷

Forward EPS (Est.)

$-1.38

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

ECOR PE Ratio Metrics

ECOR Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics